Publication: A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines
No Thumbnail Available
Date
2005
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ PUBLISHING GROUP
Abstract
Description
Keywords
PLACEBO-CONTROLLED TRIAL, INFLIXIMAB, ARTHRITIS, EFFICACY, AGENTS, SAFETY